Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT02510794

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02510794. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 10:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase II multicenter, dose-ranging, randomized, active treatment (monthly ITV injection)-controlled study to evaluate the efficacy, safety, and pharmacokinetics of ranibizumab delivered through the Implant using three ranibizumab formulation arms (10 mg/mL, 40 mg/mL, and 100 mg/mL) compared with the control arm (0.5-mg monthly ITV injections of 10-mg/mL formulation) in participants with subfoveal neovascular age-related macular degeneration (nAMD).

Study identification

NCT ID
NCT02510794
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2015 (Actual)
Primary completion
Apr 10, 2018 (Actual)
Completion
Mar 28, 2019 (Actual)
Last update posted
May 6, 2021

2015 – 2019

United States locations

U.S. sites
50
U.S. states
24
U.S. cities
46
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Mesa Arizona 85206 —
Retinal Research Institute, LLC Phoenix Arizona 85014 —
Associated Retina Consultants Phoenix Arizona 85020 —
The Retina Partners Encino California 91436 —
Jacobs Retina center at the Shiley eye Institute UCSD La Jolla California 92037 —
Jules Stein Eye Institute/ UCLA Los Angeles California 90095-7000 —
N CA Retina Vitreous Assoc Mountain View California 94040 —
Retinal Consultants Med Group Sacramento California 95825 —
West Coast Retina Medical Group San Francisco California 94109 —
UCSF; Ophthalmology San Francisco California 94143 —
Orange County Retina Med Group Santa Ana California 92705 —
California Retina Consultants Santa Barbara California 93103 —
Retina Consultants of Southern Colorado Springs Colorado 80909 —
Colorado Retina Associates, PC Lakewood Colorado 80228 —
Florida Eye Microsurgical Inst Boynton Beach Florida 33426 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Retina Specialty Institute Pensacola Florida 32503 —
Retina Vitreous Assoc of FL St. Petersburg Florida 33711 —
Retina Associates of Florida, LLC Tampa Florida 33609 —
Southeast Retina Center Augusta Georgia 30909 —
Illinois Retina Associates Joliet Illinois 60435 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Retina Associates of Kentucky Lexington Kentucky 40509 —
Paducah Retinal Center Paducah Kentucky 42001 —
Johns Hopkins Med; Wilmer Eye Inst Baltimore Maryland 21287 —
Retina Group of Washington Chevy Chase Maryland 20815 —
Retina Specialists Towson Maryland 21204 —
Vitreo-Retinal Associates, PC Worcester Massachusetts 01605 —
Foundation for Vision Research Grand Rapids Michigan 49546 —
Vitreoretinal Surgery Edina Minnesota 55435 —
Sierra Eye Associates Reno Nevada 89502 —
Retina Center of New Jersey Bloomfield New Jersey 07003 —
Mid Atlantic Retina - Wills Eye Hospital Cherry Hill New Jersey 08034 —
Eye Associates of New Mexico Albuquerque New Mexico 87102 —
University of New Mexico; School of Med Albuquerque New Mexico 87131 —
Retina Assoc of Western NY Rochester New York 14620 —
Char Eye Ear &Throat Assoc Charlotte North Carolina 28210 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Retina Northwest Portland Oregon 97221 —
Oregon HSU; Casey Eye Institute Portland Oregon 97239 —
Palmetto Retina Center Florence South Carolina 29501 —
Charles Retina Institute Germantown Tennessee 38138 —
Tennessee Retina PC. Nashville Tennessee 37203 —
Texas Retina Associates Arlington Texas 76012 —
Retina Research Center Austin Texas 78750 —
Retina Consultants of Texas Bellaire Texas 77401 —
Med Center Ophthalmology Assoc San Antonio Texas 78240 —
Retina Associates of Utah Salt Lake City Utah 84107 —
Wagner Macula & Retina Center Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02510794, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2021 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.